June 13-16, 2022, San Diego, CA 1737 Japan Pavilion

January 10-14, 2022 Hamamatsu Pharma Research available for 1-on-1 partnering sessions.

Announcing publication of Astrocyte Pharmaceuticals' efficacy evaluation of AST-004 in a NHP model of stroke in the American Heart...

HPR announces publication of a brain imaging study in a NHP model of unilateral neuropathy.

Neuroprotective effect of brimonidine in a NHP model of ocular hypertension.

Announcing Astrocyte Pharmaceuticals' efficacy study of AST-004 in a NHP model of stroke! For more details, click here

HPR's first paper about a macaque model of ulcerative colitis in 2020 is now open to everyone! Click and check the paper